Literature DB >> 20023569

Ductal carcinoma in situ: size and resection volume predict margin status.

Laleh G Melstrom1, Kurt A Melstrom, Edward C Wang, Melissa Pilewskie, David J Winchester.   

Abstract

OBJECTIVES: There is strong evidence that breast conservation surgery (BCS) with negative margins for ductal carcinoma in situ (DCIS) is associated with low rates of recurrence. Our goal was to identify factors associated with positive margins in BCS for DCIS.
METHODS: A retrospective database review identified 823 patients diagnosed with DCIS. The current analysis included 546 of those patients treated with BCS from 2000 to 2006 with complete data regarding tumor and lumpectomy dimensions. Variables analyzed included tumor size, lumpectomy volume, estrogen and progesterone receptor status, histologic subtype, grade, and age at diagnosis. χ analysis and t tests were used to identify factors that may predict positive margins. A multivariate regression model was developed to determine independent variables predictive of positive margin status.
RESULTS: A total of 33% of specimens had positive margins. Lumpectomy volume, tumor size, nuclear grade (low vs. high), and number of slides positive for DCIS were all significant for positive margin status by bivariate analysis. On multivariate analysis, tumor size (P < 0.001; odds ratio, 2.37; 95% confidence interval, 1.712, 3.296) and resection volume (P = 0.0006; odds ratio, 0.48; 95% confidence interval, 0.318, 0.729) remained significantly associated with positive margin status. Age at diagnosis, histologic subtype, tumor grade, and estrogen and progesterone status all were not associated with margin status.
CONCLUSIONS: Positive margins after BCS for DCIS are associated with larger lesions and a smaller volume of resection. With 33% of patients having positive margins, these data suggest that a more aggressive initial resection may avoid positive margins and thus lower the risk of recurrence or the need for additional surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20023569     DOI: 10.1097/COC.0b013e3181b9cf31

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  7 in total

1.  Compromised margins following mastectomy for stage I-III invasive breast cancer.

Authors:  Jennifer Yu; Fatema Al Mushawah; Marie E Taylor; Amy E Cyr; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Feng Gao; Julie A Margenthaler
Journal:  J Surg Res       Date:  2012-04-10       Impact factor: 2.192

2.  Heterogeneity of focal breast lesions and surrounding tissue assessed by mammographic texture analysis: preliminary evidence of an association with tumor invasion and estrogen receptor status.

Authors:  Balaji Ganeshan; Olga Strukowska; Karoline Skogen; Rupert Young; Chris Chatwin; Ken Miles
Journal:  Front Oncol       Date:  2011-10-17       Impact factor: 6.244

Review 3.  Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.

Authors:  A Van Cleef; S Altintas; M Huizing; K Papadimitriou; P Van Dam; W Tjalma
Journal:  Facts Views Vis Obgyn       Date:  2014

4.  Identification of Preoperative Magnetic Resonance Imaging Features Associated with Positive Resection Margins in Breast Cancer: A Retrospective Study.

Authors:  Jung-Hyun Kang; Ji Hyun Youk; Jeong-Ah Kim; Hye Mi Gweon; Na Lae Eun; Kyung Hee Ko; Eun Ju Son
Journal:  Korean J Radiol       Date:  2018-08-06       Impact factor: 3.500

5.  Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique.

Authors:  Sarianna Joukainen; Elina Laaksonen; Ritva Vanninen; Outi Kaarela; Mazen Sudah
Journal:  Ann Surg Oncol       Date:  2022-06-16       Impact factor: 4.339

6.  Efficacy and Safety of Glandular Flap Techniques in Surgical Treatment of Large Ductal Carcinoma in situ.

Authors:  Lutfi Dogan; Mehmet Ali Gulcelik
Journal:  Breast Care (Basel)       Date:  2020-05-27       Impact factor: 2.268

7.  Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast-conserving surgery-Results from a postmarketing study.

Authors:  Marc Thill; Iris Szwarcfiter; Katharina Kelling; Viviane van Haasteren; Eyal Kolka; Josefa Noelke; Zachi Peles; Moshe Papa; Sebastian Aulmann; Tanir Allweis
Journal:  J Surg Oncol       Date:  2021-11-01       Impact factor: 2.885

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.